| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.8 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.027 | 0.8 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.01 | 0.9 |